APA (7th ed.) Citation

Hernandez, I., Zhang, Y., & Saba, S. (2017). Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation. The American journal of cardiology, 120(10), 1813-1819. https://doi.org/10.1016/j.amjcard.2017.07.092

Chicago Style (17th ed.) Citation

Hernandez, Inmaculada, Yuting Zhang, and Samir Saba. "Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation." The American Journal of Cardiology 120, no. 10 (2017): 1813-1819. https://doi.org/10.1016/j.amjcard.2017.07.092.

MLA (9th ed.) Citation

Hernandez, Inmaculada, et al. "Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation." The American Journal of Cardiology, vol. 120, no. 10, 2017, pp. 1813-1819, https://doi.org/10.1016/j.amjcard.2017.07.092.